Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04180488 |
|---|---|
| Brief Title: | Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to, Intolerant of, or Incomplete Responders to Omalizumab (LIBERTY-CSU CUPID) |
| First Submitted : | November 25, 2019 |
| First Submitted that Met QC Criteria : | November 26, 2019 |
| First Posted : | November 27, 2019 |
| Last Update Submitted that Met QC Criteria : | April 9, 2024 |
| Last Update Posted : | April 11, 2024 |